-
What we know about Spain's deadly train crash
-
Neville warns managers can need sacking 'for their own good' as Carrick fights on
-
ECB chief Lagarde to step down early, triggering succession race
-
French businessman takes over 2030 Winter Olympics amid leadership turmoil
-
'Horrific' Russian drone strike kills 14 at Ukraine train station: Kyiv
-
Russell Brand found monogamy 'difficult', wife tells UK rape trial
-
VW says 'no time to lose' to slash costs after 5.8 billion euro loss
-
Dubai building that saw city's rise from desert due for demolition
-
Australia lead by 100 after Inglis century
-
Duckett's best lifts England to 386-5 in Sri Lanka dead rubber
-
Martin to ride with broken wrist in Malaysian MotoGP practice
-
Stock markets diverge on corporate earnings, tech jitters
-
England forward Toney to stand trial for alleged assault in June 2028
-
'Horrific' Russian drone strike kills 13 at Ukraine train station: Kyiv
-
Warrican's five-wicket haul leads West Indies fightback in Bangladesh Test
-
Maresca braced for another tough test in Brighton repeat
-
Oil majors reap bumper profits as Mideast war drives prices
-
Ukraine says at least 13 killed in Russian attack on train station
-
Christine Lagarde: unifying ECB chief in turbulent times
-
ECB President Christine Lagarde to step down in February 2027
-
Rybakina secures year-end top rank with Tokyo win
-
A year on, Tanzanians mourn election massacres in 'state of terror'
-
Rains bring relief to Indonesian city weary of fire haze
-
Israel piles pressure on Arab parties as Netanyahu seeks government
-
Osaka vows to return stronger after Tokyo exit
-
'Call of Duty' slammed for using real Seoul crowd crush footage
-
Hello Kitty firm apologises, scraps Japan TV tie-up after China anger
-
TotalEnergies profit hits record on high oil prices
-
Taiwan says Pakistan briefly closed airspace to Taiwanese flights
-
Key of seethe: I.Coast row with Sahel juntas spills into concert halls
-
'My blood was spilled here': a year on, Tanzania unable to mourn election violence
-
Romanian writer Cartarescu hails books as balm in turmoil
-
Afghanistan opium poppy cultivation surges despite Taliban govt ban: UN
-
Mbappe, Real Madrid and La Liga face long road to redemption in China
-
No World Series miracle for weary Rays
-
North Korea fires 'around a dozen' ballistic missiles into East Sea
-
Miami Heat earn first win of NBA season with Antetokounmpo
-
Brewers catcher Contreras named World Series MVP
-
Brewers beat Rays 4-1 to capture first World Series title
-
Asian stock markets fluctuate after mixed tech results
-
Philippine island fights rising seas with nature, not concrete
-
Samsung logs record quarterly profits despite investor AI jitters
-
Bangladesh presses India before Ganges water treaty expires
-
Miami stumble to draw against Cincinnati despite Suarez strike
-
Trump accuses Alaska Democrats of fraud over same-name scandal
-
Bangladesh scrambling as Ganges water treaty to expire
-
Spain mourns after latest train tragedy kills 68
-
England in peril with Rugby League World Cup semi spots at stake
-
Trump's border: quiet, but few people are happy
-
Antonelli ready to rewrite the Formula One record books in Mexico
US appeals court temporarily halts mail delivery of abortion pill
A US appeals court on Friday temporarily halted mail delivery of mifepristone, the medication used in the majority of abortions in the United States.
A three-judge panel of the 5th Circuit Court of Appeals delivered the order in a lawsuit brought by the southern state of Louisiana, which has some of the strictest anti-abortion laws in the country, against the Food and Drug Administration (FDA).
The order by the conservative-dominated court requires women seeking abortions anywhere in the United States to obtain mifepristone in person from health clinics, and bans delivery by mail or through a pharmacy.
The appeals court overturned a lower court ruling that allowed mifepristone to continue to be delivered by mail while the FDA conducts a review of its regulations regarding the drug.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and was published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The FDA originally approved mifepristone in 2000. It is the most common method for abortion care in the United States and is also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
Louisiana Attorney General Liz Murrill welcomed the appeals court decision calling it a "Victory for Life!"
"The Biden abortion cartel facilitated the deaths of thousands of Louisiana babies (and millions in other states) through illegal mail-order abortion pills," Murrill said. "Today, that nightmare is over."
- 'Isn't about science' -
Nancy Northup, president and CEO of the Center for Reproductive Rights, condemned the appeals court ruling, which is expected to be appealed to the US Supreme Court.
"This isn't about science -- it's about making abortion as difficult, expensive, and unreachable as possible," Northup said in a statement.
Julia Kaye, an attorney with the American Civil Liberties Union (ACLU), said "anti-abortion politicians have just made it much harder for people everywhere in the country to get a medication that abortion and miscarriage patients have been safely using for more than 25 years."
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
In 2024, the US Supreme Court rejected a bid to restrict mifepristone, ruling that anti-abortion groups and doctors challenging the medication lacked the legal standing to bring the case.
T.Ward--AMWN